|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
SIGA Technologies, Inc.
| | | Phone: | (212) 672-9100 | Fax: | (212) 697-3130 | Year Established: | 1995 | Ticker: | SIGA | Exchange: | NASDAQ | Main Contact: | Akhila Kosaraju, MD, VP, Global Development | | Other Contacts: | Phil Gomez, CEO William J. Haynes II, Executive VP & General Counsel Dennis E. Hruby, Ph.D., CSO Eric A. Rose, MD, Chairman Daniel J. Luckshire, Executive VP & CFO
| | Company Description | SIGA is a pharmaceutical company specializing in the development and commercialization of therapeutic solutions for some of the most lethal disease causing pathogens in the world - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Their business is to discover, develop, manufacture and successfully commercialize drugs to prevent and treat these high priority threats. | |
|
|
|
|
|